Skip to content

Innovative diagnostics and treatment of misophonia in children and adolescents: a new psychiatric disorder

Innovative diagnostics and treatment of misophonia in children and adolescents: a new psychiatric disorder - Diagnostics and treatment of misophonia in youth.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON52247
Enrollment
322
Registered
2021-06-09
Start date
2021-08-03
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hatred of sound misophonia

Interventions

(See also METC protocol) The intervention group and the waitinglist control group will receive treatment according to the revised protocol "Group treatment for misophonia youth (12-20 years old)".

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Eligible for participation in the healthy control group for the validation study are: children between the ages of 8 and 18 years old, without psychopathological symptoms of misophonia, not having received treatment for misophonia in the past year. Children and their parents should have provided written informed consent. Eligible for participation in the patient group of the validation study and the RCT study of treatment effectivity are: children between the ages of 8 and 18 years old, referred to the Amsterdam UMC / Levvel for diagnosis and treatment of misophonia, with treatment being indicated according to clinician, parents and / or child. Children and their parents should have provided written informed consent.

Exclusion criteria

Exclusion criteria: Validation study (healthy control group): meeting the criteria for misophonia on a psychopathological level, needing treatment; having had the diagnosis of misophonia and / or treatment for misophonia in the past year; mental retardation (estimated IQ below 85 in children and / or parents); inability to read / write or understand Dutch. Validation study (patient group) and RCT study of treatment effectivity: not meeting the inclusion criteria; does not have misophonia as primary problem domain; having psychiatric comorbid symptoms or diagnosis that hinder group functioning or require change of treatment protocol*; family problems that hinder participation or adherence to treatment protocol*; having had cognitive behavioral therapy for misophonia in the past year; self-injurious behavior (i.e. automutilation) at present or in the past year; mental retardation (estimated IQ below 85 in children and / or parents); inability to read / write or understand Dutch. * as assessed during the screening, during the intake (by a psychiatrist and/or clinical psychologist), and by the questionnaires.

Design outcomes

Primary

MeasureTime frame
(See also METC protocol) The primary outcome of the study is the severity of misophonia symptoms, as measured by the AMISOS-Y.

Secondary

MeasureTime frame
(See also METC protocol) Secundary outcomes are: - Misophonia complaints (Misophonia Screening List - Child and Youth) - Psychopathology in the child (attention and concentration problems, anxiety/depression, oppositional behavior, compulsions) - Severity of psychopathology (change over time) - School functioning - Quality of life - Attention problems - Sensory processing - Care related quality of life - Cost of illness - Social validity of treatment - Family accommodation to misophonia - Coercive disruptive behavior child

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)